nodes	percent_of_prediction	percent_of_DWPC	metapath
Alvimopan—Quinapril—hypertension	0.28	0.506	CrCtD
Alvimopan—Benazepril—hypertension	0.273	0.494	CrCtD
Alvimopan—Quinapril—Moexipril—hypertension	0.0298	0.0906	CrCrCtD
Alvimopan—Benazepril—Moexipril—hypertension	0.0284	0.0863	CrCrCtD
Alvimopan—Quinapril—Perindopril—hypertension	0.0261	0.0792	CrCrCtD
Alvimopan—Quinapril—Benazepril—hypertension	0.0241	0.0732	CrCrCtD
Alvimopan—Benazepril—Quinapril—hypertension	0.0236	0.0715	CrCrCtD
Alvimopan—Quinapril—Labetalol—hypertension	0.0214	0.0649	CrCrCtD
Alvimopan—Benazepril—Labetalol—hypertension	0.0204	0.0618	CrCrCtD
Alvimopan—Quinapril—Enalapril—hypertension	0.0204	0.0618	CrCrCtD
Alvimopan—Quinapril—Trandolapril—hypertension	0.0204	0.0618	CrCrCtD
Alvimopan—Benazepril—Trandolapril—hypertension	0.0194	0.0589	CrCrCtD
Alvimopan—Benazepril—Enalapril—hypertension	0.0194	0.0589	CrCrCtD
Alvimopan—Quinapril—Lisinopril—hypertension	0.0159	0.0484	CrCrCtD
Alvimopan—Quinapril—Ramipril—hypertension	0.0154	0.0468	CrCrCtD
Alvimopan—Benazepril—Lisinopril—hypertension	0.0152	0.0461	CrCrCtD
Alvimopan—Ketoprofen—Labetalol—hypertension	0.015	0.0454	CrCrCtD
Alvimopan—Benazepril—Ramipril—hypertension	0.0147	0.0446	CrCrCtD
Alvimopan—Indinavir—ABCC1—hypertension	0.000385	0.239	CrCbGaD
Alvimopan—Benazepril—MTHFR—hypertension	0.000238	0.148	CrCbGaD
Alvimopan—Flatulence—Acebutolol—hypertension	0.000234	0.00379	CcSEcCtD
Alvimopan—Indinavir—CYP3A5—hypertension	0.000234	0.145	CrCbGaD
Alvimopan—Anaemia—Metolazone—hypertension	0.000234	0.00379	CcSEcCtD
Alvimopan—Anaemia—Felodipine—hypertension	0.000234	0.00379	CcSEcCtD
Alvimopan—Back pain—Acebutolol—hypertension	0.00023	0.00372	CcSEcCtD
Alvimopan—Constipation—Torasemide—hypertension	0.000229	0.00371	CcSEcCtD
Alvimopan—Hypokalaemia—Telmisartan—hypertension	0.000226	0.00366	CcSEcCtD
Alvimopan—Flatulence—Eprosartan—hypertension	0.000225	0.00364	CcSEcCtD
Alvimopan—Constipation—Chlorothiazide—hypertension	0.000223	0.00361	CcSEcCtD
Alvimopan—Urinary retention—Perindopril—hypertension	0.000223	0.00361	CcSEcCtD
Alvimopan—Quinapril—ACE—hypertension	0.000223	0.138	CrCbGaD
Alvimopan—Malnutrition—Amlodipine—hypertension	0.000222	0.00359	CcSEcCtD
Alvimopan—Back pain—Eprosartan—hypertension	0.000221	0.00357	CcSEcCtD
Alvimopan—Constipation—Chlorthalidone—hypertension	0.000219	0.00354	CcSEcCtD
Alvimopan—Flatulence—Amlodipine—hypertension	0.000218	0.00353	CcSEcCtD
Alvimopan—Flatulence—Nisoldipine—hypertension	0.000218	0.00353	CcSEcCtD
Alvimopan—Constipation—Prazosin—hypertension	0.000218	0.00352	CcSEcCtD
Alvimopan—Urinary retention—Furosemide—hypertension	0.000217	0.00351	CcSEcCtD
Alvimopan—Back pain—Amlodipine—hypertension	0.000214	0.00347	CcSEcCtD
Alvimopan—Hypokalaemia—Irbesartan—hypertension	0.000213	0.00344	CcSEcCtD
Alvimopan—Dyspepsia—Bepridil—hypertension	0.000212	0.00343	CcSEcCtD
Alvimopan—Hypokalaemia—Hydrochlorothiazide—hypertension	0.000211	0.00341	CcSEcCtD
Alvimopan—Urinary tract disorder—Diltiazem—hypertension	0.00021	0.0034	CcSEcCtD
Alvimopan—Urinary tract disorder—Indapamide—hypertension	0.00021	0.0034	CcSEcCtD
Alvimopan—Dyspepsia—Penbutolol—hypertension	0.000209	0.00339	CcSEcCtD
Alvimopan—Urethral disorder—Indapamide—hypertension	0.000208	0.00337	CcSEcCtD
Alvimopan—Urethral disorder—Diltiazem—hypertension	0.000208	0.00337	CcSEcCtD
Alvimopan—Malnutrition—Guanabenz—hypertension	0.000208	0.00337	CcSEcCtD
Alvimopan—Urinary tract disorder—Carvedilol—hypertension	0.000208	0.00336	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Bepridil—hypertension	0.000208	0.00336	CcSEcCtD
Alvimopan—Hypokalaemia—Furosemide—hypertension	0.000207	0.00336	CcSEcCtD
Alvimopan—Urethral disorder—Carvedilol—hypertension	0.000206	0.00334	CcSEcCtD
Alvimopan—Constipation—Bepridil—hypertension	0.000206	0.00333	CcSEcCtD
Alvimopan—Hypokalaemia—Betaxolol—hypertension	0.000205	0.00332	CcSEcCtD
Alvimopan—Flatulence—Metoprolol—hypertension	0.000205	0.00332	CcSEcCtD
Alvimopan—Flatulence—Guanabenz—hypertension	0.000205	0.00332	CcSEcCtD
Alvimopan—Anaemia—Nisoldipine—hypertension	0.000205	0.00331	CcSEcCtD
Alvimopan—Dyspepsia—Candesartan—hypertension	0.000204	0.00331	CcSEcCtD
Alvimopan—Urinary tract disorder—Eplerenone—hypertension	0.000202	0.00327	CcSEcCtD
Alvimopan—Back pain—Guanabenz—hypertension	0.000201	0.00326	CcSEcCtD
Alvimopan—Connective tissue disorder—Eplerenone—hypertension	0.000201	0.00325	CcSEcCtD
Alvimopan—Urinary tract disorder—Nifedipine—hypertension	0.0002	0.00324	CcSEcCtD
Alvimopan—Urethral disorder—Eplerenone—hypertension	0.0002	0.00324	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Candesartan—hypertension	0.0002	0.00324	CcSEcCtD
Alvimopan—Connective tissue disorder—Nifedipine—hypertension	0.000199	0.00323	CcSEcCtD
Alvimopan—Urethral disorder—Nifedipine—hypertension	0.000199	0.00322	CcSEcCtD
Alvimopan—Dyspepsia—Amiloride—hypertension	0.000198	0.0032	CcSEcCtD
Alvimopan—Dyspepsia—Hydralazine—hypertension	0.000198	0.0032	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Methyldopa—hypertension	0.000198	0.0032	CcSEcCtD
Alvimopan—Constipation—Methyldopa—hypertension	0.000196	0.00317	CcSEcCtD
Alvimopan—Dyspepsia—Pindolol—hypertension	0.000195	0.00316	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Hydralazine—hypertension	0.000194	0.00314	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Amiloride—hypertension	0.000194	0.00314	CcSEcCtD
Alvimopan—Benazepril—ACE—hypertension	0.000194	0.12	CrCbGaD
Alvimopan—Anaemia—Guanabenz—hypertension	0.000192	0.00311	CcSEcCtD
Alvimopan—Constipation—Hydralazine—hypertension	0.000192	0.00311	CcSEcCtD
Alvimopan—Constipation—Amiloride—hypertension	0.000192	0.00311	CcSEcCtD
Alvimopan—Dyspepsia—Quinapril—hypertension	0.000192	0.00311	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Pindolol—hypertension	0.000192	0.0031	CcSEcCtD
Alvimopan—Constipation—Pindolol—hypertension	0.00019	0.00307	CcSEcCtD
Alvimopan—Dyspepsia—Benazepril—hypertension	0.000189	0.00306	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Quinapril—hypertension	0.000188	0.00305	CcSEcCtD
Alvimopan—Dyspepsia—Nadolol—hypertension	0.000188	0.00304	CcSEcCtD
Alvimopan—Constipation—Quinapril—hypertension	0.000187	0.00302	CcSEcCtD
Alvimopan—Urinary tract disorder—Valsartan—hypertension	0.000186	0.00301	CcSEcCtD
Alvimopan—Dyspepsia—Isradipine—hypertension	0.000185	0.003	CcSEcCtD
Alvimopan—Malnutrition—Indapamide—hypertension	0.000185	0.003	CcSEcCtD
Alvimopan—Malnutrition—Diltiazem—hypertension	0.000185	0.003	CcSEcCtD
Alvimopan—Urinary tract disorder—Olmesartan—hypertension	0.000185	0.00299	CcSEcCtD
Alvimopan—Connective tissue disorder—Valsartan—hypertension	0.000185	0.00299	CcSEcCtD
Alvimopan—Dyspepsia—Guanfacine—hypertension	0.000185	0.00299	CcSEcCtD
Alvimopan—Urethral disorder—Valsartan—hypertension	0.000184	0.00298	CcSEcCtD
Alvimopan—Connective tissue disorder—Olmesartan—hypertension	0.000184	0.00298	CcSEcCtD
Alvimopan—Dyspepsia—Nicardipine—hypertension	0.000184	0.00298	CcSEcCtD
Alvimopan—Constipation—Benazepril—hypertension	0.000184	0.00297	CcSEcCtD
Alvimopan—Urethral disorder—Olmesartan—hypertension	0.000184	0.00297	CcSEcCtD
Alvimopan—Malnutrition—Carvedilol—hypertension	0.000183	0.00297	CcSEcCtD
Alvimopan—Constipation—Nadolol—hypertension	0.000183	0.00296	CcSEcCtD
Alvimopan—Flatulence—Diltiazem—hypertension	0.000182	0.00295	CcSEcCtD
Alvimopan—Flatulence—Indapamide—hypertension	0.000182	0.00295	CcSEcCtD
Alvimopan—Dyspepsia—Metolazone—hypertension	0.000182	0.00294	CcSEcCtD
Alvimopan—Dyspepsia—Felodipine—hypertension	0.000182	0.00294	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Isradipine—hypertension	0.000182	0.00294	CcSEcCtD
Alvimopan—Malnutrition—Doxazosin—hypertension	0.000181	0.00293	CcSEcCtD
Alvimopan—Flatulence—Carvedilol—hypertension	0.000181	0.00292	CcSEcCtD
Alvimopan—Constipation—Isradipine—hypertension	0.00018	0.00291	CcSEcCtD
Alvimopan—Constipation—Guanfacine—hypertension	0.000179	0.0029	CcSEcCtD
Alvimopan—Back pain—Indapamide—hypertension	0.000179	0.0029	CcSEcCtD
Alvimopan—Constipation—Nicardipine—hypertension	0.000179	0.00289	CcSEcCtD
Alvimopan—Flatulence—Doxazosin—hypertension	0.000179	0.00289	CcSEcCtD
Alvimopan—Malnutrition—Eplerenone—hypertension	0.000178	0.00288	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Spironolactone—hypertension	0.000178	0.00288	CcSEcCtD
Alvimopan—Dyspepsia—Esmolol—hypertension	0.000178	0.00287	CcSEcCtD
Alvimopan—Back pain—Carvedilol—hypertension	0.000177	0.00287	CcSEcCtD
Alvimopan—Constipation—Felodipine—hypertension	0.000177	0.00286	CcSEcCtD
Alvimopan—Constipation—Metolazone—hypertension	0.000177	0.00286	CcSEcCtD
Alvimopan—Malnutrition—Nifedipine—hypertension	0.000177	0.00286	CcSEcCtD
Alvimopan—Flatulence—Fosinopril—hypertension	0.000176	0.00286	CcSEcCtD
Alvimopan—Flatulence—Eplerenone—hypertension	0.000175	0.00284	CcSEcCtD
Alvimopan—Back pain—Doxazosin—hypertension	0.000175	0.00284	CcSEcCtD
Alvimopan—Dyspepsia—Terazosin—hypertension	0.000175	0.00283	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Esmolol—hypertension	0.000174	0.00282	CcSEcCtD
Alvimopan—Flatulence—Nifedipine—hypertension	0.000174	0.00282	CcSEcCtD
Alvimopan—Urinary tract disorder—Trandolapril—hypertension	0.000173	0.00279	CcSEcCtD
Alvimopan—Constipation—Esmolol—hypertension	0.000172	0.00279	CcSEcCtD
Alvimopan—Back pain—Eplerenone—hypertension	0.000172	0.00279	CcSEcCtD
Alvimopan—Connective tissue disorder—Trandolapril—hypertension	0.000172	0.00278	CcSEcCtD
Alvimopan—Urethral disorder—Trandolapril—hypertension	0.000171	0.00277	CcSEcCtD
Alvimopan—Anaemia—Indapamide—hypertension	0.000171	0.00277	CcSEcCtD
Alvimopan—Back pain—Nifedipine—hypertension	0.000171	0.00277	CcSEcCtD
Alvimopan—Dyspepsia—Acebutolol—hypertension	0.000171	0.00276	CcSEcCtD
Alvimopan—Constipation—Terazosin—hypertension	0.00017	0.00275	CcSEcCtD
Alvimopan—Urinary tract disorder—Telmisartan—hypertension	0.00017	0.00275	CcSEcCtD
Alvimopan—Anaemia—Carvedilol—hypertension	0.000169	0.00274	CcSEcCtD
Alvimopan—Dyspepsia—Labetalol—hypertension	0.000169	0.00274	CcSEcCtD
Alvimopan—Connective tissue disorder—Telmisartan—hypertension	0.000169	0.00273	CcSEcCtD
Alvimopan—Urethral disorder—Telmisartan—hypertension	0.000168	0.00273	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Acebutolol—hypertension	0.000167	0.00271	CcSEcCtD
Alvimopan—Constipation—Acebutolol—hypertension	0.000166	0.00268	CcSEcCtD
Alvimopan—Anaemia—Fosinopril—hypertension	0.000166	0.00268	CcSEcCtD
Alvimopan—Anaemia—Eplerenone—hypertension	0.000165	0.00266	CcSEcCtD
Alvimopan—Constipation—Labetalol—hypertension	0.000164	0.00266	CcSEcCtD
Alvimopan—Dyspepsia—Eprosartan—hypertension	0.000164	0.00265	CcSEcCtD
Alvimopan—Malnutrition—Valsartan—hypertension	0.000164	0.00265	CcSEcCtD
Alvimopan—Ketoprofen—CXCL8—hypertension	0.000163	0.102	CrCbGaD
Alvimopan—Anaemia—Nifedipine—hypertension	0.000163	0.00264	CcSEcCtD
Alvimopan—Malnutrition—Olmesartan—hypertension	0.000163	0.00264	CcSEcCtD
Alvimopan—Flatulence—Valsartan—hypertension	0.000161	0.00261	CcSEcCtD
Alvimopan—Urinary tract disorder—Perindopril—hypertension	0.00016	0.00259	CcSEcCtD
Alvimopan—Urinary tract disorder—Irbesartan—hypertension	0.00016	0.00258	CcSEcCtD
Alvimopan—Constipation—Eprosartan—hypertension	0.000159	0.00258	CcSEcCtD
Alvimopan—Dyspepsia—Amlodipine—hypertension	0.000159	0.00258	CcSEcCtD
Alvimopan—Dyspepsia—Nisoldipine—hypertension	0.000159	0.00258	CcSEcCtD
Alvimopan—Urethral disorder—Perindopril—hypertension	0.000159	0.00257	CcSEcCtD
Alvimopan—Connective tissue disorder—Irbesartan—hypertension	0.000159	0.00257	CcSEcCtD
Alvimopan—Urethral disorder—Irbesartan—hypertension	0.000158	0.00256	CcSEcCtD
Alvimopan—Back pain—Valsartan—hypertension	0.000158	0.00256	CcSEcCtD
Alvimopan—Back pain—Olmesartan—hypertension	0.000158	0.00255	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Amlodipine—hypertension	0.000156	0.00253	CcSEcCtD
Alvimopan—Urinary tract disorder—Furosemide—hypertension	0.000156	0.00252	CcSEcCtD
Alvimopan—Constipation—Amlodipine—hypertension	0.000155	0.0025	CcSEcCtD
Alvimopan—Urethral disorder—Furosemide—hypertension	0.000155	0.0025	CcSEcCtD
Alvimopan—Malnutrition—Trandolapril—hypertension	0.000152	0.00246	CcSEcCtD
Alvimopan—Anaemia—Olmesartan—hypertension	0.000151	0.00244	CcSEcCtD
Alvimopan—Flatulence—Trandolapril—hypertension	0.00015	0.00243	CcSEcCtD
Alvimopan—Dyspepsia—Guanabenz—hypertension	0.00015	0.00242	CcSEcCtD
Alvimopan—Dyspepsia—Metoprolol—hypertension	0.00015	0.00242	CcSEcCtD
Alvimopan—Malnutrition—Telmisartan—hypertension	0.00015	0.00242	CcSEcCtD
Alvimopan—Flatulence—Enalapril—hypertension	0.000149	0.00242	CcSEcCtD
Alvimopan—Flatulence—Telmisartan—hypertension	0.000147	0.00238	CcSEcCtD
Alvimopan—Back pain—Trandolapril—hypertension	0.000147	0.00238	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Metoprolol—hypertension	0.000147	0.00237	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Guanabenz—hypertension	0.000147	0.00237	CcSEcCtD
Alvimopan—Back pain—Enalapril—hypertension	0.000147	0.00237	CcSEcCtD
Alvimopan—Constipation—Guanabenz—hypertension	0.000145	0.00235	CcSEcCtD
Alvimopan—Constipation—Metoprolol—hypertension	0.000145	0.00235	CcSEcCtD
Alvimopan—Back pain—Telmisartan—hypertension	0.000145	0.00234	CcSEcCtD
Alvimopan—Malnutrition—Perindopril—hypertension	0.000141	0.00228	CcSEcCtD
Alvimopan—Malnutrition—Irbesartan—hypertension	0.000141	0.00228	CcSEcCtD
Alvimopan—Anaemia—Trandolapril—hypertension	0.000141	0.00228	CcSEcCtD
Alvimopan—Anaemia—Enalapril—hypertension	0.00014	0.00227	CcSEcCtD
Alvimopan—Flatulence—Perindopril—hypertension	0.000139	0.00225	CcSEcCtD
Alvimopan—Flatulence—Irbesartan—hypertension	0.000139	0.00224	CcSEcCtD
Alvimopan—Anaemia—Telmisartan—hypertension	0.000138	0.00224	CcSEcCtD
Alvimopan—Flatulence—Hydrochlorothiazide—hypertension	0.000138	0.00223	CcSEcCtD
Alvimopan—Dyspepsia—Propranolol—hypertension	0.000137	0.00222	CcSEcCtD
Alvimopan—Malnutrition—Furosemide—hypertension	0.000137	0.00222	CcSEcCtD
Alvimopan—Back pain—Perindopril—hypertension	0.000137	0.00221	CcSEcCtD
Alvimopan—Malnutrition—Betaxolol—hypertension	0.000136	0.0022	CcSEcCtD
Alvimopan—Flatulence—Furosemide—hypertension	0.000135	0.00219	CcSEcCtD
Alvimopan—Back pain—Hydrochlorothiazide—hypertension	0.000135	0.00218	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Propranolol—hypertension	0.000135	0.00218	CcSEcCtD
Alvimopan—Anaemia—Captopril—hypertension	0.000134	0.00218	CcSEcCtD
Alvimopan—Constipation—Propranolol—hypertension	0.000133	0.00216	CcSEcCtD
Alvimopan—Dyspepsia—Indapamide—hypertension	0.000133	0.00215	CcSEcCtD
Alvimopan—Dyspepsia—Diltiazem—hypertension	0.000133	0.00215	CcSEcCtD
Alvimopan—Dyspepsia—Carvedilol—hypertension	0.000132	0.00213	CcSEcCtD
Alvimopan—Anaemia—Perindopril—hypertension	0.000131	0.00211	CcSEcCtD
Alvimopan—Flatulence—Losartan—hypertension	0.000131	0.00211	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Indapamide—hypertension	0.00013	0.00211	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Diltiazem—hypertension	0.00013	0.00211	CcSEcCtD
Alvimopan—Dyspepsia—Doxazosin—hypertension	0.00013	0.00211	CcSEcCtD
Alvimopan—Anaemia—Irbesartan—hypertension	0.00013	0.0021	CcSEcCtD
Alvimopan—Constipation—Indapamide—hypertension	0.000129	0.00209	CcSEcCtD
Alvimopan—Constipation—Diltiazem—hypertension	0.000129	0.00209	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Carvedilol—hypertension	0.000129	0.00209	CcSEcCtD
Alvimopan—Anaemia—Hydrochlorothiazide—hypertension	0.000129	0.00209	CcSEcCtD
Alvimopan—Dyspepsia—Fosinopril—hypertension	0.000129	0.00208	CcSEcCtD
Alvimopan—Connective tissue disorder—Ramipril—hypertension	0.000128	0.00207	CcSEcCtD
Alvimopan—Back pain—Losartan—hypertension	0.000128	0.00207	CcSEcCtD
Alvimopan—Constipation—Carvedilol—hypertension	0.000128	0.00207	CcSEcCtD
Alvimopan—Dyspepsia—Eplerenone—hypertension	0.000128	0.00207	CcSEcCtD
Alvimopan—Dyspepsia—Nifedipine—hypertension	0.000127	0.00205	CcSEcCtD
Alvimopan—Anaemia—Furosemide—hypertension	0.000127	0.00205	CcSEcCtD
Alvimopan—Constipation—Doxazosin—hypertension	0.000127	0.00205	CcSEcCtD
Alvimopan—Dyspepsia—Verapamil—hypertension	0.000126	0.00204	CcSEcCtD
Alvimopan—Anaemia—Betaxolol—hypertension	0.000126	0.00203	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Eplerenone—hypertension	0.000125	0.00203	CcSEcCtD
Alvimopan—Connective tissue disorder—Timolol—hypertension	0.000125	0.00203	CcSEcCtD
Alvimopan—Constipation—Fosinopril—hypertension	0.000125	0.00202	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Nifedipine—hypertension	0.000124	0.00201	CcSEcCtD
Alvimopan—Constipation—Eplerenone—hypertension	0.000124	0.00201	CcSEcCtD
Alvimopan—Constipation—Nifedipine—hypertension	0.000123	0.002	CcSEcCtD
Alvimopan—Constipation—Verapamil—hypertension	0.000123	0.00199	CcSEcCtD
Alvimopan—Anaemia—Losartan—hypertension	0.000122	0.00198	CcSEcCtD
Alvimopan—Dyspepsia—Valsartan—hypertension	0.000118	0.0019	CcSEcCtD
Alvimopan—Dyspepsia—Olmesartan—hypertension	0.000117	0.00189	CcSEcCtD
Alvimopan—Urinary tract disorder—Lisinopril—hypertension	0.000117	0.00189	CcSEcCtD
Alvimopan—Urethral disorder—Lisinopril—hypertension	0.000116	0.00188	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Valsartan—hypertension	0.000115	0.00187	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Olmesartan—hypertension	0.000115	0.00186	CcSEcCtD
Alvimopan—Constipation—Valsartan—hypertension	0.000114	0.00185	CcSEcCtD
Alvimopan—Constipation—Olmesartan—hypertension	0.000114	0.00184	CcSEcCtD
Alvimopan—Malnutrition—Ramipril—hypertension	0.000114	0.00184	CcSEcCtD
Alvimopan—Malnutrition—Timolol—hypertension	0.000111	0.0018	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Clonidine—hypertension	0.00011	0.00178	CcSEcCtD
Alvimopan—Dyspepsia—Trandolapril—hypertension	0.000109	0.00177	CcSEcCtD
Alvimopan—Constipation—Clonidine—hypertension	0.000109	0.00176	CcSEcCtD
Alvimopan—Dyspepsia—Enalapril—hypertension	0.000109	0.00176	CcSEcCtD
Alvimopan—Dyspepsia—Telmisartan—hypertension	0.000107	0.00174	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Trandolapril—hypertension	0.000107	0.00174	CcSEcCtD
Alvimopan—Constipation—Trandolapril—hypertension	0.000106	0.00172	CcSEcCtD
Alvimopan—Constipation—Enalapril—hypertension	0.000106	0.00171	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Telmisartan—hypertension	0.000105	0.00171	CcSEcCtD
Alvimopan—Dyspepsia—Captopril—hypertension	0.000104	0.00169	CcSEcCtD
Alvimopan—Constipation—Telmisartan—hypertension	0.000104	0.00169	CcSEcCtD
Alvimopan—Malnutrition—Lisinopril—hypertension	0.000103	0.00167	CcSEcCtD
Alvimopan—Constipation—Captopril—hypertension	0.000102	0.00164	CcSEcCtD
Alvimopan—Flatulence—Lisinopril—hypertension	0.000101	0.00164	CcSEcCtD
Alvimopan—Dyspepsia—Perindopril—hypertension	0.000101	0.00164	CcSEcCtD
Alvimopan—Dyspepsia—Irbesartan—hypertension	0.000101	0.00164	CcSEcCtD
Alvimopan—Dyspepsia—Hydrochlorothiazide—hypertension	0.0001	0.00162	CcSEcCtD
Alvimopan—Back pain—Lisinopril—hypertension	9.96e-05	0.00161	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Perindopril—hypertension	9.95e-05	0.00161	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Irbesartan—hypertension	9.92e-05	0.0016	CcSEcCtD
Alvimopan—Constipation—Perindopril—hypertension	9.86e-05	0.00159	CcSEcCtD
Alvimopan—Constipation—Irbesartan—hypertension	9.82e-05	0.00159	CcSEcCtD
Alvimopan—Dyspepsia—Betaxolol—hypertension	9.76e-05	0.00158	CcSEcCtD
Alvimopan—Constipation—Hydrochlorothiazide—hypertension	9.74e-05	0.00158	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Furosemide—hypertension	9.67e-05	0.00157	CcSEcCtD
Alvimopan—Constipation—Furosemide—hypertension	9.58e-05	0.00155	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Betaxolol—hypertension	9.58e-05	0.00155	CcSEcCtD
Alvimopan—Anaemia—Lisinopril—hypertension	9.52e-05	0.00154	CcSEcCtD
Alvimopan—Dyspepsia—Losartan—hypertension	9.52e-05	0.00154	CcSEcCtD
Alvimopan—Constipation—Betaxolol—hypertension	9.49e-05	0.00153	CcSEcCtD
Alvimopan—Constipation—Losartan—hypertension	9.24e-05	0.0015	CcSEcCtD
Alvimopan—Ketoprofen—PTGS1—hypertension	8.34e-05	0.0518	CrCbGaD
Alvimopan—Dyspepsia—Ramipril—hypertension	8.16e-05	0.00132	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Ramipril—hypertension	8e-05	0.00129	CcSEcCtD
Alvimopan—Dyspepsia—Timolol—hypertension	7.98e-05	0.00129	CcSEcCtD
Alvimopan—Constipation—Ramipril—hypertension	7.93e-05	0.00128	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Timolol—hypertension	7.82e-05	0.00127	CcSEcCtD
Alvimopan—Dyspepsia—Lisinopril—hypertension	7.4e-05	0.0012	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Lisinopril—hypertension	7.26e-05	0.00117	CcSEcCtD
Alvimopan—Constipation—Lisinopril—hypertension	7.19e-05	0.00116	CcSEcCtD
Alvimopan—Ketoprofen—PTGS2—hypertension	4.77e-05	0.0296	CrCbGaD
Alvimopan—Ketoprofen—ALB—hypertension	4.25e-05	0.0264	CrCbGaD
Alvimopan—OPRK1—Signaling Pathways—CXCL10—hypertension	5.43e-06	0.000102	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PLG—hypertension	5.41e-06	0.000101	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CXCL8—hypertension	5.41e-06	0.000101	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—RHOA—hypertension	5.41e-06	0.000101	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ADRA2A—hypertension	5.4e-06	0.000101	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PLAT—hypertension	5.38e-06	0.000101	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GHRL—hypertension	5.38e-06	0.000101	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—EDN1—hypertension	5.37e-06	0.0001	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—AKT2—hypertension	5.35e-06	0.0001	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—PIK3R1—hypertension	5.35e-06	0.0001	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL5—hypertension	5.33e-06	9.97e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CALCA—hypertension	5.32e-06	9.94e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ADRB2—hypertension	5.27e-06	9.86e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—LPL—hypertension	5.21e-06	9.75e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PRKCE—hypertension	5.2e-06	9.73e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—BDKRB2—hypertension	5.19e-06	9.71e-05	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—POMC—hypertension	5.18e-06	9.7e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—H2AFX—hypertension	5.17e-06	9.68e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—F2—hypertension	5.17e-06	9.67e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PRKCB—hypertension	5.17e-06	9.67e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—RPS6KB1—hypertension	5.17e-06	9.66e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PDGFRB—hypertension	5.17e-06	9.66e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PDGFA—hypertension	5.14e-06	9.61e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—VAV3—hypertension	5.14e-06	9.61e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ADRBK1—hypertension	5.13e-06	9.6e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ADCY5—hypertension	5.1e-06	9.54e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CNR1—hypertension	5.1e-06	9.53e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PRKCG—hypertension	5.07e-06	9.48e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TGFBR2—hypertension	5.07e-06	9.48e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CALM2—hypertension	5.04e-06	9.43e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PRKCA—hypertension	5.03e-06	9.42e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ITGB3—hypertension	5.03e-06	9.42e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—GNB3—hypertension	5.02e-06	9.39e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—YWHAZ—hypertension	4.99e-06	9.34e-05	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—AKT2—hypertension	4.98e-06	9.32e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HTR7—hypertension	4.97e-06	9.3e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—DRD2—hypertension	4.97e-06	9.3e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AVP—hypertension	4.95e-06	9.26e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SPP1—hypertension	4.94e-06	9.23e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NGF—hypertension	4.94e-06	9.23e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GCG—hypertension	4.92e-06	9.21e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PTPN1—hypertension	4.92e-06	9.21e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CXCL8—hypertension	4.91e-06	9.19e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—RHOA—hypertension	4.91e-06	9.18e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—GNAS—hypertension	4.89e-06	9.14e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PIK3R1—hypertension	4.86e-06	9.09e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NOTCH2—hypertension	4.83e-06	9.03e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—KL—hypertension	4.83e-06	9.03e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PRKCD—hypertension	4.8e-06	8.98e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCR5—hypertension	4.8e-06	8.98e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—APOB—hypertension	4.79e-06	8.95e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PTK2—hypertension	4.77e-06	8.92e-05	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CXCL8—hypertension	4.75e-06	8.88e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NGFR—hypertension	4.74e-06	8.86e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ITGAV—hypertension	4.74e-06	8.86e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—KNG1—hypertension	4.72e-06	8.84e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—EDN1—hypertension	4.71e-06	8.81e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—POMC—hypertension	4.71e-06	8.81e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—HTR2A—hypertension	4.7e-06	8.79e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PRL—hypertension	4.7e-06	8.78e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AGTR1—hypertension	4.7e-06	8.78e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—C3—hypertension	4.69e-06	8.78e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL5—hypertension	4.67e-06	8.74e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—STK11—hypertension	4.63e-06	8.66e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HDAC1—hypertension	4.63e-06	8.66e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCL2—hypertension	4.61e-06	8.62e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCL10—hypertension	4.59e-06	8.58e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PLG—hypertension	4.58e-06	8.56e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—LPL—hypertension	4.57e-06	8.55e-05	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—RHOA—hypertension	4.57e-06	8.55e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PDGFB—hypertension	4.57e-06	8.54e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FGFR1—hypertension	4.54e-06	8.5e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—H2AFX—hypertension	4.54e-06	8.49e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PDGFRB—hypertension	4.53e-06	8.47e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—RPS6KB1—hypertension	4.53e-06	8.47e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—AKT2—hypertension	4.53e-06	8.46e-05	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PIK3R1—hypertension	4.52e-06	8.46e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—HIF1A—hypertension	4.48e-06	8.37e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ADCY5—hypertension	4.47e-06	8.37e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AGT—hypertension	4.46e-06	8.34e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ADRB2—hypertension	4.45e-06	8.33e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PRKCG—hypertension	4.44e-06	8.31e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ITGB3—hypertension	4.41e-06	8.26e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PRKCA—hypertension	4.41e-06	8.26e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PRKCE—hypertension	4.4e-06	8.23e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CALM1—hypertension	4.38e-06	8.2e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—YWHAZ—hypertension	4.38e-06	8.19e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—LEP—hypertension	4.37e-06	8.17e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—APOE—hypertension	4.37e-06	8.17e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PDGFA—hypertension	4.34e-06	8.13e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—VAV3—hypertension	4.34e-06	8.13e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CAV1—hypertension	4.33e-06	8.1e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NGF—hypertension	4.33e-06	8.1e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SPP1—hypertension	4.33e-06	8.1e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—APOA1—hypertension	4.32e-06	8.08e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CXCL8—hypertension	4.31e-06	8.06e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TGFBR2—hypertension	4.28e-06	8.01e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—KDR—hypertension	4.28e-06	8.01e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GNB3—hypertension	4.24e-06	7.94e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PRKCD—hypertension	4.21e-06	7.88e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCR5—hypertension	4.21e-06	7.88e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AVP—hypertension	4.19e-06	7.83e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—RHOA—hypertension	4.15e-06	7.76e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GNAS—hypertension	4.13e-06	7.73e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—HTR2A—hypertension	4.12e-06	7.71e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FN1—hypertension	4.12e-06	7.71e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—F2—hypertension	4.12e-06	7.71e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PRKCB—hypertension	4.12e-06	7.71e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—C3—hypertension	4.11e-06	7.7e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PIK3R1—hypertension	4.11e-06	7.68e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—APOB—hypertension	4.05e-06	7.57e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NOTCH1—hypertension	4.03e-06	7.54e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PTK2—hypertension	4.03e-06	7.54e-05	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CXCL8—hypertension	4.01e-06	7.5e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PDGFB—hypertension	4e-06	7.49e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FGFR1—hypertension	3.98e-06	7.45e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—EDN1—hypertension	3.98e-06	7.45e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL5—hypertension	3.95e-06	7.39e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—HIF1A—hypertension	3.92e-06	7.34e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AGT—hypertension	3.91e-06	7.31e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—LPL—hypertension	3.86e-06	7.22e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CALM1—hypertension	3.84e-06	7.19e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—H2AFX—hypertension	3.83e-06	7.17e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—LEP—hypertension	3.83e-06	7.17e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—APOE—hypertension	3.83e-06	7.17e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PDGFRB—hypertension	3.83e-06	7.16e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—RPS6KB1—hypertension	3.83e-06	7.16e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CAV1—hypertension	3.8e-06	7.1e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—APOA1—hypertension	3.79e-06	7.08e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ADCY5—hypertension	3.78e-06	7.07e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PRKCG—hypertension	3.76e-06	7.02e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—KDR—hypertension	3.75e-06	7.02e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—POMC—hypertension	3.75e-06	7.02e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—INS—hypertension	3.73e-06	6.98e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ITGB3—hypertension	3.73e-06	6.98e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PRKCA—hypertension	3.73e-06	6.98e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—YWHAZ—hypertension	3.7e-06	6.92e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL2—hypertension	3.67e-06	6.87e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NGF—hypertension	3.66e-06	6.84e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SPP1—hypertension	3.66e-06	6.84e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CXCL8—hypertension	3.64e-06	6.81e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FN1—hypertension	3.61e-06	6.76e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PRKCB—hypertension	3.61e-06	6.76e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—F2—hypertension	3.61e-06	6.76e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IGF1—hypertension	3.61e-06	6.75e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AKT2—hypertension	3.61e-06	6.75e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—EGFR—hypertension	3.59e-06	6.72e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCR5—hypertension	3.56e-06	6.66e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PRKCD—hypertension	3.56e-06	6.66e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NOTCH1—hypertension	3.54e-06	6.61e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HTR2A—hypertension	3.48e-06	6.51e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—C3—hypertension	3.48e-06	6.5e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SERPINE1—hypertension	3.43e-06	6.41e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PDGFB—hypertension	3.38e-06	6.33e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FGFR1—hypertension	3.37e-06	6.3e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FGF2—hypertension	3.32e-06	6.21e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HIF1A—hypertension	3.32e-06	6.2e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—RHOA—hypertension	3.31e-06	6.19e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AGT—hypertension	3.3e-06	6.18e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—POMC—hypertension	3.29e-06	6.16e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NOS3—hypertension	3.27e-06	6.12e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PIK3R1—hypertension	3.27e-06	6.12e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—INS—hypertension	3.27e-06	6.12e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CALM1—hypertension	3.25e-06	6.08e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—LEP—hypertension	3.24e-06	6.06e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—APOE—hypertension	3.24e-06	6.06e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL2—hypertension	3.22e-06	6.02e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CAV1—hypertension	3.21e-06	6e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—APOA1—hypertension	3.2e-06	5.99e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—KDR—hypertension	3.17e-06	5.93e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IGF1—hypertension	3.17e-06	5.92e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AKT2—hypertension	3.16e-06	5.92e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—EGFR—hypertension	3.15e-06	5.89e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—RELA—hypertension	3.08e-06	5.76e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PRKCB—hypertension	3.05e-06	5.71e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FN1—hypertension	3.05e-06	5.71e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—F2—hypertension	3.05e-06	5.71e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MTOR—hypertension	3.02e-06	5.65e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SERPINE1—hypertension	3.01e-06	5.62e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NOTCH1—hypertension	2.99e-06	5.59e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FGF2—hypertension	2.91e-06	5.44e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCL8—hypertension	2.9e-06	5.43e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—RHOA—hypertension	2.9e-06	5.42e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PIK3R1—hypertension	2.87e-06	5.37e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NOS3—hypertension	2.87e-06	5.37e-05	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—AKT1—hypertension	2.8e-06	5.25e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—POMC—hypertension	2.78e-06	5.2e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—INS—hypertension	2.77e-06	5.17e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL6—hypertension	2.76e-06	5.16e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL2—hypertension	2.72e-06	5.09e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—RELA—hypertension	2.7e-06	5.05e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IGF1—hypertension	2.68e-06	5e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AKT2—hypertension	2.67e-06	5e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—EGFR—hypertension	2.66e-06	4.98e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MTOR—hypertension	2.65e-06	4.96e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MMP9—hypertension	2.63e-06	4.91e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CDKN1A—hypertension	2.62e-06	4.89e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PTEN—hypertension	2.61e-06	4.88e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MAPK8—hypertension	2.55e-06	4.78e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—AKT1—hypertension	2.55e-06	4.76e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCL8—hypertension	2.55e-06	4.76e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SERPINE1—hypertension	2.54e-06	4.75e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—EP300—hypertension	2.49e-06	4.66e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FGF2—hypertension	2.46e-06	4.6e-05	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—AKT1—hypertension	2.46e-06	4.6e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—RHOA—hypertension	2.45e-06	4.58e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NOS3—hypertension	2.43e-06	4.54e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PIK3R1—hypertension	2.43e-06	4.54e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SRC—hypertension	2.42e-06	4.53e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL6—hypertension	2.42e-06	4.53e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—VEGFA—hypertension	2.36e-06	4.41e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MMP9—hypertension	2.3e-06	4.31e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CDKN1A—hypertension	2.29e-06	4.29e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PTEN—hypertension	2.29e-06	4.28e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—RELA—hypertension	2.28e-06	4.27e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MAPK8—hypertension	2.24e-06	4.19e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MTOR—hypertension	2.24e-06	4.19e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—AKT1—hypertension	2.23e-06	4.18e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—EP300—hypertension	2.18e-06	4.08e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MYC—hypertension	2.17e-06	4.06e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TGFB1—hypertension	2.16e-06	4.05e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCL8—hypertension	2.15e-06	4.02e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SRC—hypertension	2.12e-06	3.97e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—EGFR—hypertension	2.12e-06	3.97e-05	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—AKT1—hypertension	2.08e-06	3.89e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—VEGFA—hypertension	2.07e-06	3.87e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL6—hypertension	2.05e-06	3.83e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MMP9—hypertension	1.95e-06	3.64e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CDKN1A—hypertension	1.94e-06	3.63e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PTEN—hypertension	1.93e-06	3.62e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MYC—hypertension	1.9e-06	3.56e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TGFB1—hypertension	1.9e-06	3.55e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MAPK8—hypertension	1.89e-06	3.54e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—AKT1—hypertension	1.89e-06	3.53e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—EGFR—hypertension	1.86e-06	3.48e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—EP300—hypertension	1.84e-06	3.45e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SRC—hypertension	1.79e-06	3.36e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TP53—hypertension	1.78e-06	3.33e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—VEGFA—hypertension	1.75e-06	3.27e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL6—hypertension	1.63e-06	3.05e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MYC—hypertension	1.61e-06	3.01e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TGFB1—hypertension	1.6e-06	3e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—EGFR—hypertension	1.57e-06	2.94e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TP53—hypertension	1.56e-06	2.92e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AKT1—hypertension	1.5e-06	2.81e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL6—hypertension	1.43e-06	2.67e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TP53—hypertension	1.32e-06	2.47e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AKT1—hypertension	1.32e-06	2.47e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL6—hypertension	1.21e-06	2.26e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AKT1—hypertension	1.11e-06	2.09e-05	CbGpPWpGaD
